Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Kaltsas

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
European Journal of Clinical Investigation|July 18, 2015
Metastatic pheochromocytoma and paragangliomaAnna Angelousi, Evanthia Kassi, Georgios Zografos, et al.
European Journal of Endocrinology|November 27, 2024
Vaginal bleeding in women with ovarian neuroendocrine tumor metastases should not be overlookedAnna Angelousi, Krystallenia Alexandraki, Evanthia Kassi, et al.
Endocrine|February 19, 2015
Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseasesMichail Kaklamanos, Dimitrios Thomas, Dimitrios Pikazis, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|June 19, 2023
Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic useMarina Tsoli, Anna Koumarianou, Anna Angelousi, et al.
Medicina (Kaunas, Lithuania)|October 23, 2021
Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19Ioannis Ilias, Gregory Kaltsas, Konstantinos Barkas, et al.
Neuroendocrinology|September 24, 2018
Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical MarkersKosmas Daskalakis, Gregory Kaltsas, Kjell Öberg, et al.
Endocrine Connections|July 4, 2018
Bone metabolism in Langerhans cell histiocytosisAthanasios D Anastasilakis, Marina Tsoli, Gregory Kaltsas, et al.
Hormones (Athens, Greece)|January 7, 2016
Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?Iraklis Perysinakis, Chrysanthi Aggeli, Gregory Kaltsas, et al.
BMJ Case Reports|March 24, 2017
Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET)Megan Symington, Louise Davies, Gregory Kaltsas, et al.
Neuroendocrinology|December 17, 2008
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinationsAnders Sundin, Marie-Pierre Vullierme, Gregory Kaltsas, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
European Journal of Clinical Investigation|July 18, 2015
Metastatic pheochromocytoma and paragangliomaAnna Angelousi, Evanthia Kassi, Georgios Zografos, et al.
European Journal of Endocrinology|November 27, 2024
Vaginal bleeding in women with ovarian neuroendocrine tumor metastases should not be overlookedAnna Angelousi, Krystallenia Alexandraki, Evanthia Kassi, et al.
Endocrine|February 19, 2015
Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseasesMichail Kaklamanos, Dimitrios Thomas, Dimitrios Pikazis, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|June 19, 2023
Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic useMarina Tsoli, Anna Koumarianou, Anna Angelousi, et al.
Medicina (Kaunas, Lithuania)|October 23, 2021
Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19Ioannis Ilias, Gregory Kaltsas, Konstantinos Barkas, et al.
Neuroendocrinology|September 24, 2018
Lung Carcinoids: Long-Term Surgical Results and the Lack of Prognostic Value of Somatostatin Receptors and Other Novel Immunohistochemical MarkersKosmas Daskalakis, Gregory Kaltsas, Kjell Öberg, et al.
Endocrine Connections|July 4, 2018
Bone metabolism in Langerhans cell histiocytosisAthanasios D Anastasilakis, Marina Tsoli, Gregory Kaltsas, et al.
Hormones (Athens, Greece)|January 7, 2016
Neoadjuvant therapy for advanced pancreatic neuroendocrine tumors: an emerging treatment modality?Iraklis Perysinakis, Chrysanthi Aggeli, Gregory Kaltsas, et al.
BMJ Case Reports|March 24, 2017
Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET)Megan Symington, Louise Davies, Gregory Kaltsas, et al.
Neuroendocrinology|December 17, 2008
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinationsAnders Sundin, Marie-Pierre Vullierme, Gregory Kaltsas, et al.
Pageof 23